<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01396122</url>
  </required_header>
  <id_info>
    <org_study_id>pumch-gyn-02</org_study_id>
    <nct_id>NCT01396122</nct_id>
  </id_info>
  <brief_title>Clinical Performance of GYNECARE PROSIMA* Pelvic Floor Repair System for Symptomatic Pelvic Organ Prolapse</brief_title>
  <official_title>A Prospective, Multicenter Study to Evaluate the Clinical Performance of the GYNECARE PROSIMA* Pelvic Floor Repair System as a Procedure for Symptomatic POP-Q Stage II-III Pelvic Organ Prolapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of the GYNECARE
      PROSIMA* Pelvic Floor Repair System as a Device in Women with Symptomatic Pelvic Organ
      Prolapse.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The GYNECARE PROSIMA* system is a new technique and now available in China. It provides a
      simplified unanchored mesh repair, making surgery much simpler to perform and reduces the
      risk of the specific complications that may occur when tunneling devices beyond the pelvic
      cavity.

      In clinical practice, many women have symptomatic prolapse, which requires surgical
      correction. They are relatively young, and therefore care more about the long-term outcomes
      and quality of life after procedure. The purpose of this multicenter and prospective study is
      to evaluate the effectiveness and safety of the GYNECARE PROSIMA* system in the treatment of
      symptomatic POP-Q Stage II-III pelvic organ prolapse.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anatomical improvement according to POP-Q score.</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Anatomical improvement according to POP-Q score.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Anatomical improvement according to POP-Q score.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Anatomical improvement according to POP-Q score.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Anatomical improvement according to POP-Q score.</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital data including operative time, estimated blood loss, length of stay, maximum temperature, time of voiding recovery.</measure>
    <time_frame>At discharge, an expected average of 5 days after operation.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score measured using Visual Analog Scale (VAS).</measure>
    <time_frame>24 hours after surgery and postoperation visit at the 3-4 weeks.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discomfort of balloon removal, measured using VAS at time of removal.</measure>
    <time_frame>24 hours after surgery.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject discomfort of VSD by VAS.</measure>
    <time_frame>postoperation visit at 3-4 weeks.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of complications (composite score)</measure>
    <time_frame>Up to 6 weeks.</time_frame>
    <description>The occurrence (in the per-operative phase or within 6 weeks post-op) of at least one of the following: 1) bleeding complications; 2) infectious complications; 3) any wound caused by a surgeon movement: bladder, ureteral, or vascular injuries; 4)medical complications: deep vein thrombosis, pulmonary embolism and etc. Complications will be categorized using the Dindo surgical complication grading scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in PFIQ-7 scores.</measure>
    <time_frame>6 months, 12 months, 2 years and 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In subjects sexually active at baseline, assessment of sexual function using PISQ-12 (mean scores and change from baseline).</measure>
    <time_frame>6 months, 12 months, 2 years and 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject global impression assessed on a 5 point Likert scale.</measure>
    <time_frame>6 months, 12 months, 2 years and 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of complications (composite score)</measure>
    <time_frame>Up to 3 years.</time_frame>
    <description>Long-term negative outcomes of the surgical procedure will also be recorded until 3 years after surgery. For example, mesh erosion, de novo urinary incontinence, de novo dyspareunia and overall failure rate. Complications will be categorized using the Dindo surgical complication grading scale.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Stage II-III</condition>
  <arm_group>
    <arm_group_label>PROSIMA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reconstructive surgeries with GYNECARE PROSIMA* were performed in all patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Procedure: GYNECARE PROSIMA* Pelvic Floor Repair System</intervention_name>
    <description>Perform surgery with GYNECARE PROSIMA* Pelvic Floor Repair System. Vaginal hysterectomy or mid-urethral sling procedure for incontinence could be performed concurrently.</description>
    <arm_group_label>PROSIMA group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidates with symptomatic pelvic organ prolapse of ICS POP-Q Stage II or III,
             suitable for surgical repair. Vaginal hysterectomy and mid-urethral sling procedures
             for incontinence may be performed concurrently.

          -  Age ≥ 18 years.

          -  Agrees to participate in the study, including completion of all study-related
             procedures, evaluations and questionnaires, and documents this agreement by signing
             the Ethics Committee approved informed consent.

        Exclusion Criteria:

          -  Additional surgical intervention concurrent to the procedure (e.g. sacrocolpopexy,
             paravaginal repair, tubal sterilisation).

          -  Previous repair of pelvic organ prolapse involving insertion of mesh.

          -  Previous hysterectomy within 6 months of scheduled surgery.

          -  Experimental drug or experimental medical device within 3 months prior to the planned
             procedure.

          -  Active genital, urinary or systemic infection at the time of the surgical procedure.
             Surgery may be delayed in such subjects until the infection is cleared.

          -  Coagulation disorder or on therapeutic anticoagulant therapy at the time of surgery.

          -  History of chemotherapy or pelvic radiation therapy.

          -  Systemic disease known to affect bladder or bowel function (e.g. Parkinson's disease,
             multiple sclerosis, spinal cord injury or trauma).

          -  Current evaluation or treatment for chronic pelvic pain (e.g. interstitial cystitis,
             endometriosis, coccydynia, vulvodynia).

          -  Nursing or pregnant or intends future pregnancy.

          -  Chronic cough not well-controlled.

          -  BMI≥30.

          -  In the investigator's opinion, any medical condition or psychiatric illness that could
             potentially be life threatening or affect their ability to complete the study visits
             according to this protocol.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lan Zhu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lan Zhu</last_name>
    <phone>86-10-65296238</phone>
    <email>zhu_julie@vip.sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juan Chen</last_name>
    <phone>86-13521354364</phone>
    <email>pumchcj@sina.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fujian Provincial Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Xiamen First Hospital Affiliated to Xiamen University</name>
      <address>
        <city>Xiamen</city>
        <state>Fujian</state>
        <zip>361004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Na-xuan Qiu</last_name>
      <phone>13906011647</phone>
      <email>qnx1106@sina.com</email>
    </contact>
    <investigator>
      <last_name>Na-xuan Qiu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Foshan</name>
      <address>
        <city>Foshan</city>
        <state>Guangdong</state>
        <zip>528000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gang Wang</last_name>
      <phone>86-13929928768</phone>
      <email>Wallace1971@163.com</email>
    </contact>
    <investigator>
      <last_name>Gang Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangzhou Medical College</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Peking University Shenzhen Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518036</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rui-fang Wu</last_name>
      <phone>86-13827433039</phone>
      <email>Wurf100@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Huan Li</last_name>
      <phone>86-13828700921</phone>
      <email>szbdlh@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Rui-fang Wu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The People's Hospital of Hubei Provincial</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Third Hospital of Wuhan</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Xiangya,Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guang-shi Tao</last_name>
      <phone>86-13574850167</phone>
      <email>taoguangshi@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Guang-shi Tao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Hospital Affiliated to Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wuxi Maternal and Child Health Hospital, Nanjing Medical University</name>
      <address>
        <city>Wuxi</city>
        <state>Jiangsu</state>
        <zip>214002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jian Gong</last_name>
      <phone>86-13812074116</phone>
      <email>gongjianwx@126.com</email>
    </contact>
    <investigator>
      <last_name>Jian Gong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Shengjing Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhi-jun Xia</last_name>
      <phone>86-13840118800</phone>
      <email>xiazhijunhosp2@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Qing Hu</last_name>
      <phone>86-18940255559</phone>
      <email>huq@sj-hospital.org</email>
    </contact_backup>
    <investigator>
      <last_name>Zhi-jun Xia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250033</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Shen</last_name>
      <phone>86-18980601433</phone>
      <email>shen1177@163.com</email>
    </contact>
    <investigator>
      <last_name>Hong Shen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West China Second Hospital of Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sichuan Provincial People's Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Fifth People' Hospital of Chengdu</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>611130</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mianyang Central Hospital</name>
      <address>
        <city>Mianyang</city>
        <state>Sichuan</state>
        <zip>621000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Zhang</last_name>
      <phone>86-13808110138</phone>
      <email>Zhangyong1215@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yong Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Chaoyang Hospital Affiliated to Capital University of Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenyu Zhang</last_name>
      <phone>86-13801237287</phone>
      <email>Zhenyuzhang2000@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Hong Wang</last_name>
      <phone>86-13683690370</phone>
    </contact_backup>
    <investigator>
      <last_name>Zhenyu Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100048</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong-xian Lu</last_name>
      <phone>86-13520476024</phone>
      <email>Yongxianlu@sina.com</email>
    </contact>
    <investigator>
      <last_name>Yong-xina Lu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lan Zhu</last_name>
      <phone>86-10-65296238</phone>
      <email>zhu_julie@vip.sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Juan Chen</last_name>
      <phone>86-13521354364</phone>
      <email>pumchcj@sina.com</email>
    </contact_backup>
    <investigator>
      <last_name>Lan Zhu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqin</city>
        <zip>400016</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2011</study_first_submitted>
  <study_first_submitted_qc>July 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2011</study_first_posted>
  <last_update_submitted>December 25, 2012</last_update_submitted>
  <last_update_submitted_qc>December 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

